Answer capsule
CMOs need a living rights record because models, contracts, outputs, likeness rules, and jurisdictional interpretations continue to change.
What the source establishes
- The U.S. Copyright Office maintains a multi-part AI initiative.
- Its materials address digital replicas, copyrightability, and training issues.
- Publication coverage should not be read as legal advice for a specific asset.
Rights are workflow-specific
The relevant questions differ for training inputs, reference assets, generated output, style instructions, employee work, licensed material, and a person's voice or likeness.
The accountable team should translate this point into a named workflow, affected population, source data, human owner, approval right, exception path, retained evidence, and review date. That translation is what separates an interesting AI development from a decision that can be governed and evaluated.
Contract labels are not enough
A provider's commercial-use language should be reviewed alongside indemnity, exclusions, input rights, data use, model version, and the customer's intended distribution.
The accountable team should translate this point into a named workflow, affected population, source data, human owner, approval right, exception path, retained evidence, and review date. That translation is what separates an interesting AI development from a decision that can be governed and evaluated.
Preserve human contribution
Creative teams should record meaningful human selection, arrangement, editing, and authorship decisions where ownership and provenance matter.
The accountable team should translate this point into a named workflow, affected population, source data, human owner, approval right, exception path, retained evidence, and review date. That translation is what separates an interesting AI development from a decision that can be governed and evaluated.
Maintain an asset evidence pack
For important campaigns, retain source licenses, generation records, approvals, talent releases, provider terms, and final distributed versions.
The accountable team should translate this point into a named workflow, affected population, source data, human owner, approval right, exception path, retained evidence, and review date. That translation is what separates an interesting AI development from a decision that can be governed and evaluated.
Decision test
Ask whether the source changes the decision itself, the evidence required, the implementation sequence, or only the language used to describe an existing capability. Record which claims are directly supported, which are provider statements, which require an independent test, and which remain unknown. A source-linked review should make uncertainty easier to see, not bury it inside a blended score.
Questions to take into review
- Which people and channels are represented?
- Can each insight be traced to evidence?
- What training, input, and output rights apply?
- Which review gates cover claims and brand expression?
- Which repository owns approved content?
- How are market and channel variations controlled?
- What is the optimization target?
- Which placements and audiences can be excluded?
The publication supports research and executive decision preparation. It does not provide legal, financial, accounting, employment, clinical, cybersecurity, investment, procurement, or implementation advice.